Ambev reported an 8.1% increase in Q1 net revenue despite flat volume, supported by a strong 33.6% EBITDA margin and the best Q1 operating cash flow in a decade. The company benefits from Brazil's macroeconomic tailwinds, including expected interest rate cuts and the upcoming 2026 FIFA World Cup, which may drive recovery and stabilization. While consumer and cost pressures remain risks, Ambev's solid balance sheet and minimal long-term debt underpin its Buy rating. The stock's intrinsic value is estimated at $3.83 per share, above the current $3.12, indicating attractive upside potential.
Sagimet Biosciences announced its management will participate in the Leerink Partners Therapeutics Forum on July 15, 2026, to engage with investors. The company also granted 34,300 stock options to two newly hired employees as an inducement under Nas...
In 2025, AI-related companies raised at least $200 billion in debt to finance data center buildouts, marking one of the largest tech sector financing efforts ever. Financial expert Jim Rickards highlights that much of this debt is held through comple...
Celtic Lux Holdings, formerly Alvogen Lux Holdings, purchased 10,133,333 shares of Alvotech at $3.75 per share on June 16, 2026. This transaction was reported to the Luxembourg financial regulator, CSSF, indicating significant insider activity. The p...
FTI Consulting appointed Jerome Nyssen as Senior Managing Director in its Risk Advisory practice in Australia to enhance AI-driven risk, compliance, and governance services. Nyssen brings 25 years of experience across financial services and technolog...
Dogecoin (DOGE) is approaching a crucial price zone near $0.10, a psychological level called the "zero removal rally." Currently trading around $0.084, DOGE has faced selling pressure after breaking below a support trendline but has held above $0.08,...
